| 000 | 01420 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515112217.0 | ||
| 264 | 0 | _c20080411 | |
| 008 | 200804s 0 0 rus d | ||
| 022 | _a2310-6972 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIvanov, D V | |
| 245 | 0 | 0 |
_a[Spreading and mechanisms of antimicrobial resistance of microorganisms, producing beta-lactamases. Phenotypical screening for MBL producers (carbapenemases B1) among strains of Pseudomonas genus, isolated in cases of nosocomial infections]. _h[electronic resource] |
| 260 |
_bBiomeditsinskaia khimiia _c |
||
| 300 |
_a653-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xagonists |
| 650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEdetic Acid _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xagonists |
| 650 | 0 | 4 | _aMeropenem |
| 650 | 0 | 4 |
_aPseudomonas _xenzymology |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aThienamycins _xagonists |
| 650 | 0 | 4 | _abeta-Lactamase Inhibitors |
| 650 | 0 | 4 |
_abeta-Lactamases _xmetabolism |
| 700 | 1 | _aEgorov, A M | |
| 773 | 0 |
_tBiomeditsinskaia khimiia _gvol. 53 _gno. 6 _gp. 653-61 |
|
| 999 |
_c17825566 _d17825566 |
||